CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Next Generation Chromatography Resins Manufacturer

Bio-Works has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top Next Generation Chromatography Resins Manufacturer in Europe 2026,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Lone Carlbom, CEO.

Bio-Works
When Custom Chemistry Meets Scalable Performance

Bio-Works

Lone Carlbom, Bio-Works | Life Science Review | Top Next Generation Chromatography Resins Manufacturer in EuropeLone Carlbom, CEO
Biopharmaceutical manufacturing depends on precision. Every process demands purity, yield, and scalability, but conventional resins often force scientists to compromise.

“We innovate through collaboration. Every resin we bring to market is shaped by customer input and developed on our established agarose-based platform. This approach allows Bio-Works to meet evolving purification needs with solutions that are proven, scalable, and ready for real-world manufacturing.”

The company combines classic chromatography expertise with a practical, application-driven mindset and has redefined chromatography through its custom resin solutions built for exact performance and reliable scale-up.

“We focus on scalability from day one, using the same base chemistry from development to commercial scale to de-risk tech transfer,” says Lone Carlbom, CEO. Its products stand out as innovative and cutting-edge, with exceptional performance. The company merges deep chromatography expertise with practical process insight.

Bio-Works develops agarose-based chromatography resins that achieve exceptional purity and capacity across every bioprocessing stage. Each resin design begins with the target molecule and process economics, resulting in products that deliver consistent flow, pressure stability, and easy cleaning. Its WorkBeads product line maintains the same base chemistry from R&D to commercial production, eliminating risk during scale-up and ensuring reproducible results.

Behind these solutions stands a disciplined quality framework. Bio-Works operates under an ISO 9001:2015-certified management system that documents every step, from raw materials to finished resin, ensuring full traceability. Suppliers are qualified through ESG-based supplier evaluation and controlled document discipline anchored in a clear Supplier Code of Conduct. Every operational change follows formal risk assessment and advance customer notification to maintain transparency and control.
  • We focus on scalability from day one, using the same base chemistry from development to commercial scale to de-risk tech transfer.


This structure secures both product quality and uninterrupted supply. Stage-gated manufacturing, in-process controls, business continuity planning and final release testing confirm critical parameters such as capacity, particle size, and stability. Statistical process control identifies deviations before they affect performance, while dual-qualified raw materials and safety stocks reinforce reliability. Clients receive lot comparability data and qualification packs that simplify validation and maintain continuity throughout production cycles.

Customers value Bio-Works for its technical accessibility and responsiveness. The team works directly with scientists who understand purification challenges and can refine solutions quickly. When standard formulations fall short, Bio-Works adjusts chemistry, format, or packaging without delay. Reliable delivery schedules and clear communication strengthen trust and make the company a long-term extension of the client’s process team.

Innovation drives that trust further. Bio-Works follows a voice-of-customer roadmap that directs ligand and matrix development according to real manufacturing needs. Its applications lab conducts Design of Experiments studies and scale-down trials that mirror production conditions, helping customers optimize processes before full-scale adoption. Modular chemistry and a stage-gate approach move new concepts efficiently from idea to GMP-ready materials while remaining aligned with regulatory expectations.

A case illustrates this approach. A mid-sized biotech company faced yield variability during plasmid capture, which threatened its qualification timeline. Bio-Works collaborated to refine binding and flow parameters using a customized WorkBeads resin, then provided a full validation package for review. The project improved yield consistency, shortened batch cycles, and secured successful qualification without new equipment or extended downtime.

Sustainability and measurable sustainability KPIs complements Bio-Works’ scientific precision. The company advances greener chemistries, minimizes solvent use, and optimizes resource consumption to reduce waste. Energy- and water-efficiency initiatives run alongside waste segregation and recycling programs. Bio-Works also invests in its people through workplace safety, inclusion, and continuous skill development while maintaining ethical sourcing standards. Its durable, easily cleaned resins further reduce environmental impact across product lifecycles.

Bio-Works proves that customization and collaboration can redefine purification science. The company transforms chromatography resin manufacturing into a tailored service grounded in expertise, reliability, and responsibility. For an industry seeking purity without compromise, Bio-Works delivers solutions designed around the molecule and built for the future of bioprocessing.

Next Generation Chromatography Resins Manufacturer Info

Q1

What led to Bio-Works being recognized among top next generation chromatography resin providers?

Bio-Works has earned recognition in Next Generation Chromatography Resins through its focused expertise in purifying biomolecules for biopharmaceutical applications. The company develops advanced agarose-based resins designed to deliver high purity and consistent performance across laboratory and production environments. Its ability to combine innovation with reliability, supported by strong customer collaboration and a high on-time delivery rate, reinforces its standing in Next Generation Chromatography Resins.

Q2

How does Bio-Works differentiate its chromatography resin technology?

A proprietary manufacturing process defines Bio-Works’ approach to Next Generation Chromatography Resins. Its WorkBeads platform uses highly porous agarose beads with tight size distribution, enabling superior binding capacity, mechanical stability and reproducibility. These characteristics allow efficient separation while maintaining high flow rates, which is critical for scaling from research to industrial production. This combination of precision engineering and scalability sets its Next Generation Chromatography Resins apart.

Q3

How does Bio-Works support customers in purification workflows?

Support within Next Generation Chromatography Resins at Bio-Works is structured around application knowledge and practical usability. It offers resins in both bulk formats and prepacked columns, allowing users to transition seamlessly from method development to full-scale manufacturing. The company also provides technical resources and guidance to help optimize purification processes, ensuring that customers achieve consistent results. This hands-on support strengthens the effectiveness of its Next Generation Chromatography Resins.

Q4

What value do Bio-Works’ resins bring to biopharmaceutical production?

High purity, yield and process efficiency define the value of Next Generation Chromatography Resins developed by Bio-Works. Its products are used in the purification of antibodies, proteins, peptides and even complex biologics such as viruses and vaccines. By enabling faster processing and reliable scale-up, the company helps reduce production costs while maintaining strict quality standards. These advantages make its Next Generation Chromatography Resins highly relevant to modern biomanufacturing.

Q5

What role do expertise and innovation play in Bio-Works’ offerings?

Scientific expertise and continuous innovation are central to Bio-Works’ Next Generation Chromatography Resins. Founded by specialists in protein purification, the company integrates deep domain knowledge with ongoing research and development to refine resin performance. Its portfolio spans multiple chromatography techniques, including affinity, ion exchange and size exclusion, ensuring compatibility with diverse purification needs. This breadth of expertise supports the advancement of Next Generation Chromatography Resins.

Q6

Why is Bio-Works relevant to evolving biopharmaceutical needs?

The increasing complexity of biologics has created demand for more efficient purification tools, and Bio-Works addresses this with its Next Generation Chromatography Resins. Its solutions enable consistent performance across different scales and applications, supporting faster development and production of therapeutic products. By focusing on quality, scalability and application-specific design, the company remains aligned with the evolving requirements of the biopharmaceutical industry.

Top Next Generation Chromatography Resins Manufacturer in Europe 2026
Current Issue

Company : Bio-Works

Management
Lone Carlbom, CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/bio-works